Epygenix Therapeutics Announces First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100

Read Full Press Release Here:

https://www.prnewswire.com/news-releases/epygenix-therapeutics-announces-first-patient-enrolled-in-phase-2-study-for-the-treatment-of-dravet-syndrome-with-epx-100-301144613.html